LAVA Therapeutics NV

NAS:LVTX (Netherlands)  
$ 0.98 -0.0086 (-0.87%) 11:08 PM EST
At Loss
P/B:
0.78
Market Cap:
$ 25.87M
Enterprise V:
$ -45.51M
Volume:
37.67K
Avg Vol (2M):
111.56K
Trade In:
Volume:
37.67K
At Loss
Avg Vol (2M):
111.56K

Business Description

Description
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 12.54
Equity-to-Asset 0.4
Debt-to-Equity 0.19
Debt-to-EBITDA -0.25
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.56
Distress
Grey
Safe
Beneish M-Score -2.94
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.19
9-Day RSI 27.22
14-Day RSI 30.87
6-1 Month Momentum % -14.44
12-1 Month Momentum % 5.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.36
Quick Ratio 5.36
Cash Ratio 5.19
Days Sales Outstanding 43.64
Days Payable 11491.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.2
Shareholder Yield % 0.66

Financials (Next Earnings Date:2025-03-20 Est.)

LVTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LVTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

LAVA Therapeutics NV Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 7.345
EPS (TTM) ($) -1.01
Beta 0.32
Volatility % 113.18
14-Day RSI 30.87
14-Day ATR ($) 0.131033
20-Day SMA ($) 1.367145
12-1 Month Momentum % 5.96
52-Week Range ($) 0.96 - 6.47
Shares Outstanding (Mil) 26.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

LAVA Therapeutics NV Filings

Filing Date Document Date Form
No Filing Data

LAVA Therapeutics NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

LAVA Therapeutics NV Frequently Asked Questions

What is LAVA Therapeutics NV(LVTX)'s stock price today?
The current price of LVTX is $0.98. The 52 week high of LVTX is $6.47 and 52 week low is $0.96.
When is next earnings date of LAVA Therapeutics NV(LVTX)?
The next earnings date of LAVA Therapeutics NV(LVTX) is 2025-03-20 Est..
Does LAVA Therapeutics NV(LVTX) pay dividends? If so, how much?
LAVA Therapeutics NV(LVTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1